MED insider trading
NYSE Consumer CyclicalMEDIFAST INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About MEDIFAST INC
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans consisting of 5 & 1 Plan and 5 & 1 ACTIVE Plan, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss without the stress of figuring out what to eat. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.
Company website: medifastinc.com
MED insider activity at a glance
FilingIQ has scored 467 insider transactions for MED since Feb 17, 2015. The most recent filing in our index is dated May 11, 2026.
Across the full history, 80 open-market purchases
and 116 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on MED insider trades is 46.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest MED Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Consumer Cyclical tickers with recent insider activity
Top insiders trading MED
Frequently asked
- How many insider trades does FilingIQ track for MED?
- FilingIQ tracks 467 Form 4 insider transactions for MED (MEDIFAST INC), covering filings from Feb 17, 2015 onwards. 17 of those were filed in the last 90 days.
- Are MED insiders net buyers or net sellers?
- Across the full Form 4 history for MED, 80 transactions (17%) were open-market purchases and 116 (25%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does MED insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is MED in?
- MEDIFAST INC (MED) is classified in the Consumer Cyclical sector, specifically Personal Services, with a current market capitalisation of $115.30M.
Methodology & sources
Every MED insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.